Analysts Set Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Target Price at $18.25
Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on […]
29 Mar 01:22 · The Cerbat Gem